drugset / Trial / NCT01900522
Safety and Tolerability of Multiple Doses of ITI-214 in Healthy Adults and in Adults With Stable Schizophrenia
RandomizedParallel-groupQuadruple-blind
Summary
The purpose of this study is to characterize the safety and tolerability profile of ITI-214 when administered as multiple doses of oral solution at escalating dose levels.
Timeline
- Start
- 2013-07
- Primary completion
- 2014-09
- Completion
- 2014-12
Outcome
Outcome not reported
Stopped (Business): “Business Decision; No Safety or Efficacy Concerns”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lenrispodun | Small molecule | — | Oral |